Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00635154 · FLOW

Participant flow

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma · Source last updated 2018-06-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. id
    FG000
    title
    Anakinra With/Without Dexamethasone
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        8
      type
      Alternative Treatment
    2. reasons
      1. group Id
        FG000
        num Subjects
        4
      type
      Other
    3. reasons
      1. group Id
        FG000
        num Subjects
        21
      type
      Still on treatment
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        21
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        33
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Patients received induction therapy of Anakinra alone for 6 months. Based on response, dexamethasone could be added or increased in subsequent cycles. See the Outline section for more detail. Unless otherwise stated, results are reported for all patients (regardless of dexamethasone administration).
recruitment Details
55 patients were recruited from November 2002 through December 2007 at Mayo Clinic. One patient had progressive disease prior to starting treatment. This patient was excluded from all analysis.
Complete source fields
groups
  1. id
    FG000
    title
    Anakinra With/Without Dexamethasone
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        8
      type
      Alternative Treatment
    2. reasons
      1. group Id
        FG000
        num Subjects
        4
      type
      Other
    3. reasons
      1. group Id
        FG000
        num Subjects
        21
      type
      Still on treatment
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        21
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        33
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Patients received induction therapy of Anakinra alone for 6 months. Based on response, dexamethasone could be added or increased in subsequent cycles. See the Outline section for more detail. Unless otherwise stated, results are reported for all patients (regardless of dexamethasone administration).
recruitment Details
55 patients were recruited from November 2002 through December 2007 at Mayo Clinic. One patient had progressive disease prior to starting treatment. This patient was excluded from all analysis.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice